Ebaresdax (hydrochloride)

• UNSPSC Description:

  Ebaresdax (ACP-044) hydrochloride can inhibit peroxynitrite oxidation derived by SIN-1 and peroxynitrite mediated Cytotoxicity with IC50s of 3.7±0.80 and 0.13±0.02 uM, respectively[1].

• Target Antigen:

  Endogenous Metabolite

• Type:

  Reference compound

• Related Pathways:

  Metabolic Enzyme/Protease

• Applications:

  Neuroscience-Neuromodulation

• Field of Research:

  Neurological Disease

• Assay Protocol:

  https://www.medchemexpress.com/ebaresdax-hydrochloride.html

• Solubility:

  10 mM in DMSO

• Smiles:

  OC([C@H](C(C)(S1)C)N=C1NC2=C(C=CC=C2)O)=O.[H]Cl

• Molecular Weight:

  302.78

• References & Citations:

  [1]Mannion, James C.; Dax, Scott L. Analgesic compounds, compositions, and uses thereof. WO2011112602A1.

• Shipping Conditions:

  Room temperature

• Clinical Information:

  Phase 2

• CAS Number:

  1334385-87-3